Hussein A Kassam, MD | |
Unm Dept Of Internal Medicine, Msc10 5550, 1 University Of New Mexico, Albuquerque, NM 87131 | |
(505) 272-4661 | |
Not Available |
Full Name | Hussein A Kassam |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | Unm Dept Of Internal Medicine, Albuquerque, New Mexico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669632683 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Hussein A Kassam, MD Unm Dept Of Internal Medicine, Msc10 5550, 1 University Of New Mexico, Albuquerque, NM 87131 Ph: (505) 272-4661 | Hussein A Kassam, MD Unm Dept Of Internal Medicine, Msc10 5550, 1 University Of New Mexico, Albuquerque, NM 87131 Ph: (505) 272-4661 |
News Archive
A new study finds a wide state-by-state variation in rates of melanoma caused by ultraviolet (UV) exposure with highest rates in several states on the East and West Coast including Hawaii, but also a few landlocked states, including Utah, Vermont, and Minnesota.
Children who are exposed to high levels of traffic-related pollution and high levels of indoor endotoxin early in life have six times the risk of developing persistent wheezing by age three than children exposed to low levels of traffic and indoor-related pollutants, according to new research from the University of Cincinnati College of Medicine.
HITECH Answers, a leading provider of educational resources on the HITECH Act, the ARRA stimulus benefits and Meaningful Use (MU) announced today a unique marketing and distribution partnership with UBM Medica.
Banner Pharmacaps Inc. has confirmed that its Abbreviated New Drug Application for Bexarotene 75 mg soft gelatin capsules, a generic version of Targretin, has been accepted for review by the US Food and Drug Administration.
The electronic technology equipment designed by the researchers- which is in patent process-is based on molecular imaging, a type of biomedical imaging capable of detecting live cellular processes. "These techniques differ from conventional medical imaging in that the information they show is function not form, which means that they are capable of showing the malfunctioning of an organ before the malfunction turns into an anatomical change", Juan Jos- Vaquero explained.
› Verified 6 days ago